Buy

CORT Quote, Financials, Valuation and Earnings

Last price:

$51.46

Seasonality move :

11.1%

Day range:

$50.02 - $52.35

52-week range:

$20.84 - $62.22

Dividend yield:

0%

P/E ratio:

40.82x

P/S ratio:

9.12x

P/B ratio:

8.44x

Volume:

2.4M

Avg. volume:

937.3K

1-year change:

66.55%

Market cap:

$5.4B

Revenue:

$482.4M

EPS (TTM):

$1.26

Corcept Therapeutics SEC Filings

Company	Filed	Form Type	Description
CORT Corcept Therapeutics	05/01/2024	10-Q	10-Q filing on 05/01/2024	View Form
CORT Corcept Therapeutics	11/01/2023	10-Q	10-Q filing on 11/01/2023	View Form
CORT Corcept Therapeutics	08/02/2023	10-Q	10-Q filing on 08/02/2023	View Form
CORT Corcept Therapeutics	05/03/2023	10-Q	10-Q filing on 05/03/2023	View Form
CORT Corcept Therapeutics	11/03/2022	10-Q	10-Q filing on 11/03/2022	View Form
CORT Corcept Therapeutics	08/04/2022	10-Q	10-Q filing on 08/04/2022	View Form
CORT Corcept Therapeutics	05/05/2022	10-Q	10-Q filing on 05/05/2022	View Form
CORT Corcept Therapeutics	11/03/2021	10-Q	10-Q filing on 11/03/2021	View Form
CORT Corcept Therapeutics	07/29/2021	10-Q	10-Q filing on 07/29/2021	View Form
CORT Corcept Therapeutics	05/06/2021	10-Q	10-Q filing on 05/06/2021	View Form
CORT Corcept Therapeutics	11/03/2020	10-Q	10-Q filing on 11/03/2020	View Form
CORT Corcept Therapeutics	08/04/2020	10-Q	10-Q filing on 08/04/2020	View Form
CORT Corcept Therapeutics	05/04/2020	10-Q	10-Q filing on 05/04/2020	View Form
CORT Corcept Therapeutics	02/24/2020	10-K	10-K filing on 02/24/2020	View Form
CORT Corcept Therapeutics	11/07/2019	10-Q	10-Q filing on 11/07/2019	View Form
CORT Corcept Therapeutics	08/01/2019	10-Q	10-Q filing on 08/01/2019	View Form
CORT Corcept Therapeutics	05/09/2019	10-Q	10-Q filing on 05/09/2019	View Form
CORT Corcept Therapeutics	02/26/2019	10-K	10-K filing on 02/26/2019	View Form
CORT Corcept Therapeutics	11/02/2018	10-Q	10-Q filing on 11/02/2018	View Form
CORT Corcept Therapeutics	08/09/2018	10-Q	10-Q filing on 08/09/2018	View Form
CORT Corcept Therapeutics	05/09/2018	10-Q	10-Q filing on 05/09/2018	View Form
CORT Corcept Therapeutics	02/28/2018	10-K	10-K filing on 02/28/2018	View Form
CORT Corcept Therapeutics	11/03/2017	10-Q	10-Q filing on 11/03/2017	View Form
CORT Corcept Therapeutics	08/02/2017	10-Q	10-Q filing on 08/02/2017	View Form
CORT Corcept Therapeutics	05/02/2017	10-Q	10-Q filing on 05/02/2017	View Form
CORT Corcept Therapeutics	03/06/2017	10-K	10-K filing on 03/06/2017	View Form
CORT Corcept Therapeutics	11/02/2016	10-Q	10-Q filing on 11/02/2016	View Form
CORT Corcept Therapeutics	08/03/2016	10-Q	10-Q filing on 08/03/2016	View Form
CORT Corcept Therapeutics	05/04/2016	10-Q	10-Q filing on 05/04/2016	View Form
CORT Corcept Therapeutics	03/10/2016	10-K	10-K filing on 03/10/2016	View Form
CORT Corcept Therapeutics	11/06/2015	10-Q	10-Q filing on 11/06/2015	View Form
CORT Corcept Therapeutics	08/07/2015	10-Q	10-Q filing on 08/07/2015	View Form
CORT Corcept Therapeutics	05/08/2015	10-Q	10-Q filing on 05/08/2015	View Form
CORT Corcept Therapeutics	03/13/2015	10-K	10-K filing on 03/13/2015	View Form

Related Companies

Get CORT Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

CORT

Sector

P/E ratio

40.82x

25.86x

PEG ratio

0.73x

0.00x

P/B ratio

8.44x

1.85x

Price / LTM sales

9.12x

1.86x

Growth Metrics

CORT

Sector

Revenue growth

47.69%

7.28%

Earnings growth

46.43%

1.82%

Revenue (5-year growth)

13.94%

8.73%

Earnings forecast

$0.29

-$0.20

Profitability

CORT

Sector

Profitability FY 2023

$475.9M

$57.1M

Return on invested capital

25.77%

-14.06%

Return on assets

21.04%

-11.77%

Return on equity

25.77%

-14.78%

Earnings Date

Last Earnings Date

Oct

30

Next Earnings Date

Feb

14

Estimated Next Earnings Date

Jan

29

Balance Sheet

CORT

Sector

Total cash

$380.3M

$47M

Short term investments

$232.7M

$45.2M

Total assets

$621.5M

$142.6M

Long term debt

--

$6.5M

Stock Ideas

Buy

64

Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy or Sell?

Buy

52

Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy or Sell?

Buy

55

Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Buy or Sell?

Alerts

Buy

61

QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Buy or Sell?

Sell

46

NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Buy or Sell?

Sell

1

IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Corcept Therapeutics SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get CORT Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

Will Tyson Foods Stock Bounce Back?

Will Iovance Biotherapeutics Stock Bounce Back?

Stock Ideas

Is AAPL Stock a Buy?

Is NVDA Stock a Buy?

Is MSFT Stock a Buy?

Alerts

QMCO alert for Dec 21

NUKK alert for Dec 21

IIPR alert for Dec 21

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS